Characteristics and outcomes of ibrutinib-associated musculoskeletal toxicities in CLL patients Meeting Abstract


Authors: Rhodes, J.; Mato, A.; Hubbard, R.; Chong, E.; Winchell, N.; Kennard, K.; Nasta, S.; Landsburg, D.; Gerson, J.; Barta, S.; Svoboda, J.; Loren, A.; Lo Re, V.; Schuster, S.
Abstract Title: Characteristics and outcomes of ibrutinib-associated musculoskeletal toxicities in CLL patients
Meeting Title: 18th International Workshop on Chronic Lymphocytic Leukemia
Journal Title: Leukemia and Lymphoma
Volume: 61
Issue: Suppl. 1
Meeting Dates: 2019 Sept 20-23
Meeting Location: Edinburgh, United Kingdom
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2020-01-01
Start Page: 73
End Page: 76
Language: English
ACCESSION: WOS:000534385400055
PROVIDER: wos
PUBMED: 32436402
DOI: 10.1080/10428194.2020.1732667
Notes: Meeting Abstract: 1990 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato